The Impact of Social Determinants on Pancreatic Cancer Care in the United States
by
, , ,
Shreeja N. Patel
,
Joseph R. Habib
,
Daniel Brock Hewitt
,
Michael D. Kluger
,
Katherine Morgan
,
Ammar A. Javed
,
Christopher L. Wolfgang
and
Greg D. Sacks
* Department of Surgery, New York University Langone Health, New York, NY 10016, USA
*
Author to whom correspondence should be addressed.
Cancers 2025, 17(12), 1898; https://doi.org/10.3390/cancers17121898
Submission received: 21 March 2025
/
Revised: 4 June 2025
/
Accepted: 4 June 2025
/
Published: 6 June 2025
(This article belongs to the Special Issue Impact of Social Determinants on Cancer Care)
Simple Summary
Pancreatic cancer is associated with a dismal 5-year survival rate. Despite the advent of more effective multimodal chemotherapies and novel surgical techniques, outcomes remain poor. This is largely attributed to delay in diagnosis given only one in every five patients has resectable disease at the time of presentation. Social determinants of health, namely economic stability, education, race, and insurance status, also play an important role in cancer-related outcomes. Initiatives to address the disparities in pancreatic cancer care target one or more social determinants. These initiatives focus on expanding access to quality multidisciplinary care for all patients with pancreatic cancer regardless of cost, insurance status, education level, and race.
Excerpt
Note: In lieu of an abstract, this is an excerpt from the first page.
With a rising annual incidence, pancreatic cancer is now the third leading cause of cancer-related mortality in American men and women [...]
Keywords:
pancreatic cancer; social determinants
